Evidence map›Paper›PMID 40133381›Full record

ArticleScientific reports2025

Demography, sanitation and previous disease prevalence associate with COVID-19 deaths across Indian States.

Bithika Chatterjee, Shekhar C Mande

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bithika ChatterjeeNational Centre for Cell Science, NCCS Complex, Ganeshkhind, Pune, 411007, India.
Shekhar C MandeNational Centre for Cell Science, NCCS Complex, Ganeshkhind, Pune, 411007, India. shekhar.mande@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severity of COVID-19 has varied across regions, with a disproportionately higher case-fatality ratio in developed nations. In India, states with higher income have reported more COVID-19 related deaths compared to lower-income states. Understanding the underlying factors such as demographics, disease burden, urbanization, and sanitation can help in designing better public health policies to mitigate future pandemics. The objective of this study is to identify key predictors of COVID-19 mortality across Indian states by examining the role of disease prevalence, demographics, urbanization, and sanitation. We analysed data from the Global Burden of Diseases India 2019 and the National Health Profile 2019, correlating them with COVID-19 mortality during two peak periods of the pandemic. Spearman correlation analysis and multivariate regression models were employed to determine significant associations and build predictive models for COVID-19 deaths. Our analysis showed a positive correlation between COVID-19 mortality and demographic factors such as the percentage of the elderly population (ρ = 0.44, p < 0.05 for the first peak; ρ = 0.46, p < 0.05 for the second peak). Urbanization was also significantly associated with higher mortality (ρ = 0.71, p < 0.05 for the first peak; ρ = 0.57, p < 0.05 for the second peak). Additionally, the prevalence of autoimmune diseases and cancer correlated positively with deaths. An unexpected finding was the positive correlation between improved sanitation (e.g., closed drainage systems and indoor toilets) and COVID-19 mortality. The best-fit multivariate regression model, combining demographics, sanitation, autoimmune diseases, and cancer, achieved an adjusted R

Indexed as

COVID-19SanitationDemographyFemaleHumansIndiaMalePandemicsPrevalenceSARS-CoV-2UrbanizationAutoimmune diseasesCancerCOVID-19HygieneIndian StatesRisk factors

Identifiers

PMID40133381
PMCPMC11937543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.